Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity.

MLA

Mortensen, Joachim Høg, et al. “Specific Calprotectin Neo-Epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity.” Journal of Crohn’s & Colitis, vol. 16, no. 9, Sept. 2022, pp. 1447–60. EBSCOhost, https://doi.org/10.1093/ecco-jcc/jjac047.

APA

Mortensen, J. H., Sinkeviciute, D., Manon-Jensen, T., Domislović, V., McCall, K., Thudium, C. S., Brinar, M., Önnerfjord, P., Goodyear, C. S., Krznarić, Ž., Karsdal, M. A., & Bay-Jensen, A.-C. (2022). Specific Calprotectin Neo-epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity. Journal of Crohn’s & Colitis, 16(9), 1447–1460. https://doi.org/10.1093/ecco-jcc/jjac047

Chicago

Mortensen, Joachim Høg, Dovile Sinkeviciute, Tina Manon-Jensen, Viktor Domislović, Kathryn McCall, Christian S Thudium, Marko Brinar, et al. 2022. “Specific Calprotectin Neo-Epitope [CPa9-HNE] in Serum from Inflammatory Bowel Disease Patients Is Associated with Neutrophil Activity and Endoscopic Severity.” Journal of Crohn’s & Colitis 16 (9): 1447–60. doi:10.1093/ecco-jcc/jjac047.